EFFECTS OF STEM CELL TREATMENT IN HUMAN PATIENTS WITH PEYRONIE DISEASE

Effects of Stem Cell Treatment in Human Patients With Peyronie Disease Jason A. Levy, OMS III, MS; Melissa Marchand, PA-C; Leanne Iorio, OMS I; Gilles Zribi; Michael P. Zahalsky, MD Author Notes The Journal of the American Osteopathic Association, October 2015, Vol. 115, e8-e13. doi:10.7556/jaoa.2015.124 Abstract Context: Peyronie disease (PD) is a connective tissue disorder…

AUTOLOGOUS ADIPOSE DERIVED STROMAL VASCULAR FRACTION COMBINED WITH LOW INTENSITY SHOCK WAVE THERAPY FOR THE TREATMENT OF PEYRONIES DISEASE-A PILOT STUDY

AUTOLOGOUS ADIPOSE DERIVED STROMAL VASCULAR FRACTION COMBINED WITH LOW INTENSITY SHOCK WAVE THERAPY FOR THE TREATMENT OF PEYRONIES DISEASE-A PILOT STUDY Elliot B. Lander MD, Mark L. Berman MD*, Jackie R. See M.D. California Stem Cell Treatment Center and Cell Surgical Network INTRODUCTION: We evaluated the safety and efficacy of deployment of SVF Stromal Vascular…

Cell Surgical Network Study for Stromal Vascular Fraction Registered by ClinicalTrials.gov

Rancho Mirage, CA (PRWEB) October 14, 2013 Clinicaltrials.gov, a service of the U.S. National Institutes of Health has registered on their public site an IRB approved safety study from the Cell Surgical Network, Inc.. This study is available for patients with various degenerative and inflammatory conditions to undergo Stromal Vascular Fraction deployment for the evaluation and for the…

Peyronie’s disease: advances in basic science and pathophysiology.

Curr Urol Rep. 2000 Dec;1(4):297-301. Peyronie’s disease: advances in basic science and pathophysiology. Bivalacqua TJ, Purohit SK, Hellstrom WJ. Source Department of Urology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA. Abstract Peyronie’s disease is an idiopathic, localized connective tissue disorder of the penis that involves the tunica albuginea of…

Tracking intracavernously injected adipose-derived stem cells to bone marrow.

Tracking intracavernously injected adipose-derived stem cells to bone marrow. Lin G, Qiu X, Fandel T, Banie L, Wang G, Lue TF, Lin CS. Source Knuppe Molecular Urology Laboratory, Department of Urology, School of Medicine, University of California, San Francisco, CA 94143-0738, USA. Abstract The intracavernous (i.c.) injection of stem cells (SCs) has been shown to…

Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia.

Circulation. 2006 Dec 19;114(25):2823-30. Epub 2006 Dec 4. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, Dimmeler S. Source Department of Medicine III, University of Frankfurt, Theodor-Stern-Kai 7, 60590…

Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.

JAMA. 2013 Apr 17;309(15):1622-31. doi: 10.1001/jama.2013.3527. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial. Assmus B, Walter DH, Seeger FH, Leistner DM, Steiner J, Ziegler I, Lutz A, Khaled W, Klotsche J, Tonn T, Dimmeler S, Zeiher AM. Source Division of Cardiology, Department…

low-intensity extracorporeal shock wave therapy–a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy.

J Urol. 2012 May;187(5):1789-90. doi: 10.1016/j.juro.2012.01.102. Epub 2012 Mar 15. low-intensity extracorporeal shock wave therapy–a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. Seftel AD.     Palmieri A, Imbimbo C, Longo N, Fusco F, Verze P, Mangiapia F, Creta M, Mirone V. Source Department of Urology, University Federico II of Naples, Naples, Italy. Erratum in Eur Urol. 2009…

Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’sdisease and erectile dysfunction: results from a prospective randomized trial.

Int J Androl. 2012 Apr;35(2):190-5. doi: 10.1111/j.1365-2605.2011.01226.x. Epub 2011 Nov 15. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’sdisease and erectile dysfunction: results from a prospective randomized trial. Palmieri A, Imbimbo C, Creta M, Verze P, Fusco F, Mirone V. Source Department of Urology, University Federico II of Naples, Naples, Italy. Abstract Extracorporeal shock wave therapy improves erectile function in patients with Peyronie’s disease. However,…

Extracorporeal shock wave therapy in the treatment of Peyronie’s disease: long-term results.

Arch Ital Urol Androl. 2010 Jun;82(2):128-33. Extracorporeal shock wave therapy in the treatment of Peyronie’s disease: long-term results. De Berardinis E, Busetto GM, Antonini G, Giovannone R, Gentile V. Source Policlinico Umberto I, Dipartimento Urologia “U. Bracci”, Sapienza Università di Roma, Italy. Erratum in Arch Ital Urol Androl. 2010 Sep;82(3):III. De Berardinis, Ettore [added]; Antonini, Gabriele [added]; Giovannone, Riccardo [added]; Gentile, Vincenzo [added]. Abstract PURPOSE: Controversial data…